This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,956.50 firm fixed-price delivery order is for the supply of Trulicity 4.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of December 20, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award represents a task order under that larger IDC framework, demonstrating AmerisourceBergen's role as a critical vendor for the federal government's medical supply needs.
Generated 3/20/25, 9:55 AM